Lexitas Around The Web

How Allgenesis Evaluated Unique Endpoints to Advance its Phase

In this webinar, Sally Tucker, President of Global Services for Lexitas, is joined by the leadership team of Voxeleron and Allgenesis to discuss their collaboration on a recent phase two study for diabetic macular edema (DME). The panelists highlight the importance of imaging and biomarkers in ophthalmology clinical trials and share their experiences working with […]

From Patient Care to Research: Dr. Bruce Segal’s Journey

Welcome back to the InFocus podcast series, hosted by Dr. Andrew Pucker, Senior Director of Clinical Medical Sciences at Lexitas Pharma Surfaces. In this episode, Dr. Pucker sits down with Dr. Bruce Segal, an experienced ophthalmologist based in Delray Beach, Florida, to delve into the world of medical research. Dr. Segal shares his journey into […]

The Impact of Contact Lens Wear On the Ocular Surface w/ Dr. Joe Shovlin

In this episode of the Infocus podcast series, host Dr. Andrew Pucker is joined by Dr. Joe Shovlin to discuss the impact of contact lenses on the ocular surface. The conversation revolves around a paper from the Tear Film and Ocular Surface Society (TFOS) titled “Impact of Contact Lenses on the Ocular Surface” and its […]

Lifestyle Impact On Ocular Health w/ Dr. Sheetal Shah

In this episode of the “In Focus” podcast series, Dr. Sheetal Shah, Cornea and External Disease Specialist sits with Dr. Andrew Pucker, Senior Director of Clinical Medical Science at Lexitas Pharma Services to discuss the impact of cosmetics on the ocular surface. They delve into the findings of the Tear Film and Ocular Surface Society’s […]

How Exonate Plans to Revolutionize Diabetic Eye Disease Treatment: A Convo with Dr. Catherine Beech

In this episode of “In Focus,” Julie Schlosser sits down with Dr. Catherine Beech, CEO of biotech company Exonate, to discuss their cutting-edge work in ophthalmology. Exonate is focused on developing a groundbreaking eye drop treatment for diabetic eye disease, aiming to replace the need for invasive injections into the eye. Dr. Beech shares the […]

Best-Corrected Visual Acuity Testing In Clinical Practice and Clinical Trials

Congrats to Drs. Winston Posvar and Andrew D. Pucker, OD, PhD, for being published in The Ophthalmologist with their article summarizing the pros and cons of visual acuity testing. Learn how Snellen and ETDRS methods are best utilized in clinical trials. Check Out More

The Future Of Decentralized Clinical Trials In Ophthalmology

In decentralized clinical trials (DCTs), investigators reduce dependence on intermediary specialists and traditional facilities for data acquisition by using virtual elements to facilitate treatment and data collection in a subject’s home.1 As clinical trials shift toward a more decentralized model, telemedicine is poised to play a more substantial role. Check out more

Overcoming Barriers to Ophthalmic Studies: Advice from the Experts YouTube (Video)

How can ophthalmic sponsors’ anticipate and prepare for the biggest challenges in their study? Check out our four-minute video that can save you weeks of frustration. With expert advice from multiple experts who have conducted hundreds of ophthalmology clinical trials. Our In Focus newsletter is published once a month and has thousands of subscribers. To help you […]

Trends in Ophthalmology Clinical Trials (Video)

Ophthalmic clinical trials are increasing in complexity, as novel endpoints, new innovations in gene therapy and advances in AI are helping to push the boundaries of what was previously possible. Listen to CRO experts in clinical operations and ophthalmology talk about the trends and opportunities in clinical studies for eye disease. Our In Focus newsletter is published […]

The State of the Ophthalmology Funding Landscape

Lexitas Pharma Services CEO and Executive Chairwoman Jeanne Hecht joins Triangle Business Journal President and Publisher Jason Christie to talk about Lexitas’ recent growth and where it’s headed as the new year approaches. See More Our In Focus newsletter is published once a month and has thousands of subscribers. To help you keep in touch, you can subscribe […]

A Deeper Look at Pegcetacoplan (via Optometry Times Journal)

The US Food and Drug Administration (FDA) approved pegcetacoplan (Syfovre; Apellis Pharmaceuticals) in February 2023 for the treatment of geographic atrophy (GA) in patients with advanced age-related macular degeneration (AMD), and now, for the first time, the community has a treatment option for dry AMD beyond vitamins. Pegcetacoplan is an intravitreal drug and, unlike anti-VEGF (vascular endothelial growth factor) injections, it […]

Dry Eye Renaissance: Escalating Cases Meet With Innovation

Two decades ago, managing dry eye disease was straightforward. Practitioners were able to offer a few options: artificial tears, prescription cyclosporine ophthalmic emulsion (Restasis; Allergan), and punctal occlusion. Since then, our options have multiplied. With novel treatments and diagnostics approved by the FDA and additional strategies in the pipeline, we’ve entered an era of innovative management for […]

From Operating Room To Board Room w/ George Magrath, M.D.

The following is a summary the Totally Clinical podcast with Dr. George Magrath, the CEO of Lexitas Pharma Services, a contract research organization focused on ophthalmic drug development. What sets George apart is his dual role as a physician actively practicing medicine alongside his responsibilities as a CEO. This unique combination provides him with a […]

Teckro Podcast w/ Dr. George Magrath – From Scrubs to CEO

Check out Teckro’s podcast on Lexitas CEO Dr. George Magrath. George discusses his unique dual perspective on patient care as both a CEO and a physician. He shares how his double role gives him a better understanding of patient needs and helps Lexitas to stand out in a competitive market. Listen to the podcast via […]

Opportunities in the Ophthalmic Drug and Device Development Space w/ George MacGrath, via NYSE

Pharmaceutical and biotechnology companies developing ophthalmology products have their eye on Lexitas Pharma Services for clinical trial services. Hear from our own CEO George Magrath about the opportunities he sees coming out in the ophthalmic drug and device development space. Transcript: I’m Judy Shaw for NYSC floor Talk joining me today is George Magrath he is CEO at Lexitas […]

Targeting Eye Disease from a Doctor’s Perspective – Lexitas Pharma CEO George Magrath, live from NYSE

IPO Edge hosted a fireside chat from the floor of the New York Stock Exchange with George Magrath, M.D., Chief Executive Officer of Lexitas Pharma. Dr. Magrath, who continues to practice medicine part time, spoke to IPO Edge Editor-in-Chief John Jannarone about investments in pharma and life sciences companies, how ophthalmic startups are different than other pharma startups […]

Ophthalmologist Runs a Private Practice and a 200 Member Niche CRO Simultaneously! via The Clinical Trials Guru

Check out Dr. George Macgrath Lexitas CEO on The Clinical Trials Guru Transcript: Hey, Guru nation. Welcome back to another episode we try to cover all different topics of our lovely clinical research industry, ranging from tech vendors to sites to career seekers to CROs and sponsors today we’ve got an interesting story. We’ve got […]

Female Disruptors – Joanna Williams Interview, via Authority Magazine

Female Disruptors: Joanna Williams of Lexitas Pharma Services On The Three Things You Need To Shake Up Your Industry As a part of our series about women who are shaking things up in their industry, we had the pleasure of interviewing Joanna Williams. Joanna Williams is Co-Founder and Chief Operating Officer at Lexitas Pharma Services, […]

Inspiring Innovation w/ Dr. George Magrath, via The Ophthalmologist

My career journey has been rather unorthodox! During my ophthalmology residency, one of the things that I noticed in our area of South Carolina there was very little care for people with ocular cancer – so I went to Wills Eye Hospital for a couple of years of training in ocular oncology, then came back […]

RamaOnHealthcare Interview w/ Dr. George Magrath

RamaOnHealthcare talks with Dr. George Magrath, the CEO of Lexitas, which holds ophthalmic clinical trials for drug companies. Dr. Magrath discusses emerging trends in clinical trials and ophthalmics and, as a vocal proponent of “pharma for good,” what needs to change in drug development.See More